# Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor

> **NCT00304720** · PHASE2 · UNKNOWN · sponsor: **Colorado Blood Cancer Institute** · enrollment: 40 (estimated)

## Conditions studied

- Multiple Myeloma
- Lymphoma
- Acute Myelogenous Leukemia
- Acute Lymphocytic Leukemia
- Myelodysplastic Syndrome

## Interventions

- **DRUG:** Tacrolimus and MMF

## Key facts

- **NCT ID:** NCT00304720
- **Lead sponsor:** Colorado Blood Cancer Institute
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2004-03
- **Primary completion:** —
- **Final completion:** —
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2008-02-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00304720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00304720, "Tacrolimus and MMF as Post Grafting Immunosuppression After Conditioning With Flu TBI for HLA Matched Family Donor". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00304720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*